ASTRO 2020: First Clinical Applications of ExacTrac Dynamic

Head of the Radiotherapy and Palliative Care Department at UZ Brussel

Summary:

Prof. Mark De Ridder graduated at the medical school of the Vrije Universiteit Brussel (VUB) in 1998 with summa cum lauda. He combined his training in Radiotherapy and Oncology with a doctoral fellowship (FWO-Vlaanderen) and defended his PhD “Hypoxic tumor cell radiosensitization through nitric oxide synthase: role of the NF-kB signalling pathway” in 2005. He was nominated professor in Radiation Oncology and Research at the VUB in 2008 and Head of the Radiotherapy Department of the UZ Brussel in 2010. Mark is vice-chairman of the board of directors and vice-president of the medical council of the UZ Brussel, as well as the Head of Palliative and Supportive Care at CHU Brugmann.

Prof. De Ridder’s translational research program is focused on stereotactic radiotherapy, colorectal cancer and breast cancer. He is the promoter of 9 successfully defended PhD theses and has a total of 155 articles in publication.

His services include:

• Member of the FWO (Research Foundation – Flanders) expert panel for Cancer Research
• Member of the biomedical committee of “Kom op tegen Kanker”
• Member of the Flemish recognition committee for Oncology – Radiotherapy

Mark de Ridder about his own experience being one of the first center being certified:

“We are pleased to be one of the first two centers in Belgium to receive Novalis Certification. This accreditation program stands for high standards in patient safety and reinforces our processes and procedures for these highly complex treatments. This confirms our leading position for linac-based radiosurgery of brain lesions in Belgium.”